BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 11275933)

  • 1. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
    Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
    Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
    Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
    J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative scintigraphic analysis of 123I-MIBG by polar map in patients with dilated cardiomyopathy.
    Yamazaki J; Muto H; Ishiguro S; Okamoto K; Hosoi H; Nakano H; Morishita T
    Nucl Med Commun; 1997 Mar; 18(3):219-29. PubMed ID: 9106775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of effect of beta-blocker therapy in patients with dilated cardiomyopathy by using 123I-BMIPP, 123I-MIBG scintigraphy].
    Inoue A; Yamazaki J; Nanjou S; Togane Y; Amano H
    Kaku Igaku; 2001 Mar; 38(2):99-104. PubMed ID: 11345771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
    Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
    Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical meaning of 123I-MIBG myocardial SPeCT in patients with dilated cardiomyopathy].
    Yamazaki J; Hosoi H; Yamashina H; Kabano T; Yamashina S; Nanjo S; Matsukawa S; Morishita T; Okamoto K; Ohsawa H
    Kaku Igaku; 1994 Apr; 31(4):373-7. PubMed ID: 8196234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis.
    Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1356-61. PubMed ID: 15221293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of 123I-MIBG scintigraphy for prediction of effect of beta-blocker therapy in dilated cardiomyopathy].
    Tawarahara K; Sugiyama T; Nakano T; Matou F; Kurata C; Wakabayashi Y; Shouda S; Mikami T
    Kaku Igaku; 1998 Jul; 35(6):413-20. PubMed ID: 9753920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
    Suwa M; Otake Y; Moriguchi A; Ito T; Hirota Y; Kawamura K; Adachi I; Narabayashi I
    Am Heart J; 1997 Mar; 133(3):353-8. PubMed ID: 9060806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
    Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
    J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of metaiodobenzylguanidine for assessing status of ends of myocardial sympathetic nerves in myocardium of patients with bronchial asthma].
    Boĭtsov SA; Kuchmin AN; Beozertseva IV; Karetkina EI; Iudina OV; Medvedeva EV
    Ter Arkh; 2003; 75(3):15-8. PubMed ID: 12718212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
    Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
    J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of meta-[123I]iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy who receive long-term beta blocker treatment.
    Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
    Nucl Med Commun; 2005 Feb; 26(2):97-102. PubMed ID: 15657500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
    Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
    Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cardiac adrenergic nervous system after transmyocardial laser revascularisation assessed by I-123-MIBG SPECT. A preliminary report.
    Teresińska A; Sliwiński M; Konieczna S; Szumilak B; Szymańska M; Debski A; Hendzel P; Juraszyński Z
    Kardiol Pol; 2004 Jan; 60(1):15-26. PubMed ID: 15004628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.